129 related articles for article (PubMed ID: 3087874)
1. Statine-containing dipeptide and tripeptide inhibitors of human renin.
Kokubu T; Hiwada K; Nagae A; Murakami E; Morisawa Y; Yabe Y; Koike H; Iijima Y
Hypertension; 1986 Jun; 8(6 Pt 2):II1-5. PubMed ID: 3087874
[TBL] [Abstract][Full Text] [Related]
2. In vitro inhibition of human renin by statine-containing tripeptide renin inhibitor (ES-1005).
Kokubu T; Hiwada K; Murakami E; Muneta S; Morisawa Y; Yabe Y; Koike H; Iijima Y
J Cardiovasc Pharmacol; 1987; 10 Suppl 7():S88-90. PubMed ID: 2485069
[TBL] [Abstract][Full Text] [Related]
3. Highly potent and specific inhibitors of human renin.
Kokubu T; Hiwada K; Murakami E; Imamura Y; Matsueda R; Yabe Y; Koike H; Iijima Y
Hypertension; 1985; 7(3 Pt 2):I8-11. PubMed ID: 2987128
[TBL] [Abstract][Full Text] [Related]
4. A highly potent and long-acting oral inhibitor of human renin.
Hiwada K; Kokubu T; Murakami E; Muneta S; Morisawa Y; Yabe Y; Koike H; Iijima Y
Hypertension; 1988 Jun; 11(6 Pt 2):708-12. PubMed ID: 3134306
[TBL] [Abstract][Full Text] [Related]
5. [In vitro and in vivo inhibition of renin by a thiazolylalanyl cyclostatine derivative].
Muneta S
Nihon Jinzo Gakkai Shi; 1989 Aug; 31(8):865. PubMed ID: 2512401
[TBL] [Abstract][Full Text] [Related]
6. Highly potent and specific inhibitors of human renin.
Kokubu T; Hiwada K; Sato Y; Iwata T; Imamura Y; Matsueda R; Yabe Y; Kogen H; Yamazaki M; Iijima Y
Biochem Biophys Res Commun; 1984 Feb; 118(3):929-33. PubMed ID: 6422931
[TBL] [Abstract][Full Text] [Related]
7. Renin inhibitors. Syntheses of subnanomolar, competitive, transition-state analogue inhibitors containing a novel analogue of statine.
Boger J; Payne LS; Perlow DS; Lohr NS; Poe M; Blaine EH; Ulm EH; Schorn TW; LaMont BI; Lin TY
J Med Chem; 1985 Dec; 28(12):1779-90. PubMed ID: 3906131
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of porcine pepsin by two substrate analogues containing statine. The effect of histidine at the P2 subsite on the inhibition of aspartic proteinases.
Maibaum J; Rich DH
J Med Chem; 1988 Mar; 31(3):625-9. PubMed ID: 3126296
[TBL] [Abstract][Full Text] [Related]
9. Highly potent and specific inhibitors of human renin.
Sham HL; Stein H; Rempel CA; Cohen J; Plattner JJ
FEBS Lett; 1987 Aug; 220(2):299-301. PubMed ID: 3111889
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological activity of some transition-state inhibitors of human renin.
Bühlmayer P; Caselli A; Fuhrer W; Göschke R; Rasetti V; Rüeger H; Stanton JL; Criscione L; Wood JM
J Med Chem; 1988 Sep; 31(9):1839-46. PubMed ID: 3137345
[TBL] [Abstract][Full Text] [Related]
11. Design, structure-activity, and molecular modeling studies of potent renin inhibitory peptides having N-terminal Nin-For-Trp (Ftr): angiotensinogen congeners modified by P1-P1' Phe-Phe, Sta, Leu psi[CH(OH)CH2]Val or leu psi[CH2NH]Val substitutions.
Sawyer TK; Pals DT; Mao B; Staples DJ; de Vaux AE; Maggiora LL; Affholter JA; Kati W; Duchamp D; Hester JB
J Med Chem; 1988 Jan; 31(1):18-30. PubMed ID: 3275777
[TBL] [Abstract][Full Text] [Related]
12. Renin inhibitors containing hydrophilic groups. Tetrapeptides with enhanced aqueous solubility and nanomolar potency.
Bock MG; DiPardo RM; Evans BE; Freidinger RM; Rittle KE; Payne LS; Boger J; Whitter WL; LaMont BI; Ulm EH
J Med Chem; 1988 Oct; 31(10):1918-23. PubMed ID: 3050088
[TBL] [Abstract][Full Text] [Related]
13. Syntheses and biological activities of renin inhibitors containing statine analogues.
Nishi T; Saito F; Nagahori H; Kataoka M; Morisawa Y; Yabe Y; Sakurai M; Higashida S; Shoji M; Matsushita Y
Chem Pharm Bull (Tokyo); 1990 Jan; 38(1):103-9. PubMed ID: 2110866
[TBL] [Abstract][Full Text] [Related]
14. Pepstatin inhibition mechanism.
Marciniszyn J; Hartsuck JA; Tang J
Adv Exp Med Biol; 1977; 95():199-210. PubMed ID: 339690
[TBL] [Abstract][Full Text] [Related]
15. ES-8891, an orally active inhibitor of human renin.
Kokubu T; Hiwada K; Murakami E; Muneta S; Kitami Y; Salmon PF
Hypertension; 1990 Jun; 15(6 Pt 2):909-13. PubMed ID: 2112512
[TBL] [Abstract][Full Text] [Related]
16. Analysis of structure-activity relationships in renin substrate analogue inhibitory peptides.
Hui KY; Carlson WD; Bernatowicz MS; Haber E
J Med Chem; 1987 Aug; 30(8):1287-95. PubMed ID: 3302256
[TBL] [Abstract][Full Text] [Related]
17. Novel renin inhibitors containing the amino acid statine.
Boger J; Lohr NS; Ulm EH; Poe M; Blaine EH; Fanelli GM; Lin TY; Payne LS; Schorn TW; LaMont BI; Vassil TC; Stabilito II; Veber DF; Rich DH; Bopari AS
Nature; 1983 May 5-11; 303(5912):81-4. PubMed ID: 6341856
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a potent inhibitor of subprimate and primate renins.
Wood JM; Mah SC; Baum HP; de Gasparo M; Cumin F; Rüeger H; Nussberger J
J Pharmacol Exp Ther; 1990 May; 253(2):513-7. PubMed ID: 2110974
[TBL] [Abstract][Full Text] [Related]
19. Mode of inhibition of acid proteases by pepstatin.
Marciniszyn J; Hartsuck JA; Tang J
J Biol Chem; 1976 Nov; 251(22):7088-94. PubMed ID: 993206
[TBL] [Abstract][Full Text] [Related]
20. Design of potent substrate-analogue inhibitors of canine renin.
Hui KY; Siragy HM; Haber E
Int J Pept Protein Res; 1992 Aug; 40(2):152-60. PubMed ID: 1446972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]